Global Sinusitis Drugs Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	178 Pages	TechNavio	August, 2024	INF19178784

Best Price Guarantee
Price	from $2,500
Length	178 Pages
Publisher	TechNavio
Published Date	August, 2024
SKU	INF19178784

Global Sinusitis Drugs Market 2024-2028

Sinusitis Drugs Market 2024-2028

The sinusitis drugs market is forecasted to grow by USD 735.7 mn during 2023-2028, accelerating at a CAGR of 5.53% during the forecast period. The report on the sinusitis drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of sinusitis, growing awareness among people about sinusitis treatment, and increasing mergers and acquisitions among vendors.

Technavio's sinusitis drugs market is segmented as below:

By Product

Steroid nasal sprays
Antibiotics
Decongestants
Others

By Disease Type

Acute sinusitis
Chronic sinusitis
Sub-acute sinusitis

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing investments in research and development by major players as one of the prime reasons driving the sinusitis drugs market growth during the next few years. Also, advent of biologics and technological advances in sinusitis drugs will lead to sizable demand in the market.

The report on the sinusitis drugs market covers the following areas:

Sinusitis drugs market sizing
Sinusitis drugs market forecast
Sinusitis drugs market industry analysis

The vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading sinusitis drugs market vendors that include AbbVie Inc., Alembic Pharmaceuticals Ltd., Aurobindo Pharma Ltd., Bayer AG, Bionpharma Inc., CHIESI Farmaceutici SpA, Cipla Inc., DR Reddys Laboratories Ltd., Fresenius SE and Co. KGaA, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Johnson and Johnson Services Inc., Merck and Co. Inc., Neopharma Corp., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teligent Inc., and Teva Pharmaceutical Industries Ltd.. Also, the sinusitis drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Product; Executive Summary - Chart on Market Segmentation by Disease Type; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Sinusitis Drugs Market 2018 - 2022; Historic Market Size - Data Table on Global Sinusitis Drugs Market 2018 - 2022 ($ million); 4.2 Product segment analysis 2018 - 2022; Historic Market Size - Product Segment 2018 - 2022 ($ million); 4.3 Disease Type segment analysis 2018 - 2022; Historic Market Size - Disease Type Segment 2018 - 2022 ($ million); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product: 6.1 Market segments; Chart on Product - Market share 2023-2028 (%); Data Table on Product - Market share 2023-2028 (%); 6.2 Comparison by Product; Chart on Comparison by Product; Data Table on Comparison by Product; 6.3 Steroid nasal sprays - Market size and forecast 2023-2028; Chart on Steroid nasal sprays - Market size and forecast 2023-2028 ($ million); Data Table on Steroid nasal sprays - Market size and forecast 2023-2028 ($ million); Chart on Steroid nasal sprays - Year-over-year growth 2023-2028 (%); Data Table on Steroid nasal sprays - Year-over-year growth 2023-2028 (%); 6.4 Antibiotics - Market size and forecast 2023-2028; Chart on Antibiotics - Market size and forecast 2023-2028 ($ million); Data Table on Antibiotics - Market size and forecast 2023-2028 ($ million); Chart on Antibiotics - Year-over-year growth 2023-2028 (%); Data Table on Antibiotics - Year-over-year growth 2023-2028 (%); 6.5 Decongestants - Market size and forecast 2023-2028; Chart on Decongestants - Market size and forecast 2023-2028 ($ million); Data Table on Decongestants - Market size and forecast 2023-2028 ($ million); Chart on Decongestants - Year-over-year growth 2023-2028 (%); Data Table on Decongestants - Year-over-year growth 2023-2028 (%); 6.6 Others - Market size and forecast 2023-2028; Chart on Others - Market size and forecast 2023-2028 ($ million); Data Table on Others - Market size and forecast 2023-2028 ($ million); Chart on Others - Year-over-year growth 2023-2028 (%); Data Table on Others - Year-over-year growth 2023-2028 (%); 6.7 Market opportunity by Product; Market opportunity by Product ($ million); Data Table on Market opportunity by Product ($ million)
7 Market Segmentation by Disease Type: 7.1 Market segments; Chart on Disease Type - Market share 2023-2028 (%); Data Table on Disease Type - Market share 2023-2028 (%); 7.2 Comparison by Disease Type; Chart on Comparison by Disease Type; Data Table on Comparison by Disease Type; 7.3 Acute sinusitis - Market size and forecast 2023-2028; Chart on Acute sinusitis - Market size and forecast 2023-2028 ($ million); Data Table on Acute sinusitis - Market size and forecast 2023-2028 ($ million); Chart on Acute sinusitis - Year-over-year growth 2023-2028 (%); Data Table on Acute sinusitis - Year-over-year growth 2023-2028 (%); 7.4 Chronic sinusitis - Market size and forecast 2023-2028; Chart on Chronic sinusitis - Market size and forecast 2023-2028 ($ million); Data Table on Chronic sinusitis - Market size and forecast 2023-2028 ($ million); Chart on Chronic sinusitis - Year-over-year growth 2023-2028 (%); Data Table on Chronic sinusitis - Year-over-year growth 2023-2028 (%); 7.5 Sub-acute sinusitis - Market size and forecast 2023-2028; Chart on Sub-acute sinusitis - Market size and forecast 2023-2028 ($ million); Data Table on Sub-acute sinusitis - Market size and forecast 2023-2028 ($ million); Chart on Sub-acute sinusitis - Year-over-year growth 2023-2028 (%); Data Table on Sub-acute sinusitis - Year-over-year growth 2023-2028 (%); 7.6 Market opportunity by Disease Type; Market opportunity by Disease Type ($ million); Data Table on Market opportunity by Disease Type ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.9 UK - Market size and forecast 2023-2028; Chart on UK - Market size and forecast 2023-2028 ($ million); Data Table on UK - Market size and forecast 2023-2028 ($ million); Chart on UK - Year-over-year growth 2023-2028 (%); Data Table on UK - Year-over-year growth 2023-2028 (%); 9.10 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ million); Data Table on China - Market size and forecast 2023-2028 ($ million); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.11 France - Market size and forecast 2023-2028; Chart on France - Market size and forecast 2023-2028 ($ million); Data Table on France - Market size and forecast 2023-2028 ($ million); Chart on France - Year-over-year growth 2023-2028 (%); Data Table on France - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 AbbVie Inc.; AbbVie Inc. - Overview; AbbVie Inc. - Product / Service; AbbVie Inc. - Key news; AbbVie Inc. - Key offerings; 12.4 Alembic Pharmaceuticals Ltd.; Alembic Pharmaceuticals Ltd. - Overview; Alembic Pharmaceuticals Ltd. - Product / Service; Alembic Pharmaceuticals Ltd. - Key offerings; 12.5 Bayer AG; Bayer AG - Overview; Bayer AG - Business segments; Bayer AG - Key news; Bayer AG - Key offerings; Bayer AG - Segment focus; 12.6 Dr Reddys Laboratories Ltd.; Dr Reddys Laboratories Ltd. - Overview; Dr Reddys Laboratories Ltd. - Business segments; Dr Reddys Laboratories Ltd. - Key news; Dr Reddys Laboratories Ltd. - Key offerings; Dr Reddys Laboratories Ltd. - Segment focus; 12.7 Fresenius SE and Co. KGaA; Fresenius SE and Co. KGaA - Overview; Fresenius SE and Co. KGaA - Business segments; Fresenius SE and Co. KGaA - Key news; Fresenius SE and Co. KGaA - Key offerings; Fresenius SE and Co. KGaA - Segment focus; 12.8 GlaxoSmithKline Plc; GlaxoSmithKline Plc - Overview; GlaxoSmithKline Plc - Business segments; GlaxoSmithKline Plc - Key news; GlaxoSmithKline Plc - Key offerings; GlaxoSmithKline Plc - Segment focus; 12.9 Hikma Pharmaceuticals Plc; Hikma Pharmaceuticals Plc - Overview; Hikma Pharmaceuticals Plc - Business segments; Hikma Pharmaceuticals Plc - Key news; Hikma Pharmaceuticals Plc - Key offerings; Hikma Pharmaceuticals Plc - Segment focus; 12.10 Johnson and Johnson Services Inc.; Johnson and Johnson Services Inc. - Overview; Johnson and Johnson Services Inc. - Business segments; Johnson and Johnson Services Inc. - Key news; Johnson and Johnson Services Inc. - Key offerings; Johnson and Johnson Services Inc. - Segment focus; 12.11 Merck and Co. Inc.; Merck and Co. Inc. - Overview; Merck and Co. Inc. - Business segments; Merck and Co. Inc. - Key news; Merck and Co. Inc. - Key offerings; Merck and Co. Inc. - Segment focus; 12.12 Neopharma Corp.; Neopharma Corp. - Overview; Neopharma Corp. - Product / Service; Neopharma Corp. - Key offerings; 12.13 Novartis AG; Novartis AG - Overview; Novartis AG - Business segments; Novartis AG - Key news; Novartis AG - Key offerings; Novartis AG - Segment focus; 12.14 Pfizer Inc.; Pfizer Inc. - Overview; Pfizer Inc. - Product / Service; Pfizer Inc. - Key news; Pfizer Inc. - Key offerings; 12.15 Sanofi SA; Sanofi SA - Overview; Sanofi SA - Business segments; Sanofi SA - Key news; Sanofi SA - Key offerings; Sanofi SA - Segment focus; 12.16 Sun Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd. - Overview; Sun Pharmaceutical Industries Ltd. - Product / Service; Sun Pharmaceutical Industries Ltd. - Key news; Sun Pharmaceutical Industries Ltd. - Key offerings; 12.17 Teva Pharmaceutical Industries Ltd.; Teva Pharmaceutical Industries Ltd. - Overview; Teva Pharmaceutical Industries Ltd. - Business segments; Teva Pharmaceutical Industries Ltd. - Key news; Teva Pharmaceutical Industries Ltd. - Key offerings; Teva Pharmaceutical Industries Ltd. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Product; Exhibits6: Executive Summary - Chart on Market Segmentation by Disease Type; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Sinusitis Drugs Market 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Product Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Disease Type Segment 2018 - 2022 ($ million); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on Product - Market share 2023-2028 (%); Exhibits33: Data Table on Product - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by Product; Exhibits35: Data Table on Comparison by Product; Exhibits36: Chart on Steroid nasal sprays - Market size and forecast 2023-2028 ($ million); Exhibits37: Data Table on Steroid nasal sprays - Market size and forecast 2023-2028 ($ million); Exhibits38: Chart on Steroid nasal sprays - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on Steroid nasal sprays - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on Antibiotics - Market size and forecast 2023-2028 ($ million); Exhibits41: Data Table on Antibiotics - Market size and forecast 2023-2028 ($ million); Exhibits42: Chart on Antibiotics - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on Antibiotics - Year-over-year growth 2023-2028 (%); Exhibits44: Chart on Decongestants - Market size and forecast 2023-2028 ($ million); Exhibits45: Data Table on Decongestants - Market size and forecast 2023-2028 ($ million); Exhibits46: Chart on Decongestants - Year-over-year growth 2023-2028 (%); Exhibits47: Data Table on Decongestants - Year-over-year growth 2023-2028 (%); Exhibits48: Chart on Others - Market size and forecast 2023-2028 ($ million); Exhibits49: Data Table on Others - Market size and forecast 2023-2028 ($ million); Exhibits50: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits51: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits52: Market opportunity by Product ($ million); Exhibits53: Data Table on Market opportunity by Product ($ million); Exhibits54: Chart on Disease Type - Market share 2023-2028 (%); Exhibits55: Data Table on Disease Type - Market share 2023-2028 (%); Exhibits56: Chart on Comparison by Disease Type; Exhibits57: Data Table on Comparison by Disease Type; Exhibits58: Chart on Acute sinusitis - Market size and forecast 2023-2028 ($ million); Exhibits59: Data Table on Acute sinusitis - Market size and forecast 2023-2028 ($ million); Exhibits60: Chart on Acute sinusitis - Year-over-year growth 2023-2028 (%); Exhibits61: Data Table on Acute sinusitis - Year-over-year growth 2023-2028 (%); Exhibits62: Chart on Chronic sinusitis - Market size and forecast 2023-2028 ($ million); Exhibits63: Data Table on Chronic sinusitis - Market size and forecast 2023-2028 ($ million); Exhibits64: Chart on Chronic sinusitis - Year-over-year growth 2023-2028 (%); Exhibits65: Data Table on Chronic sinusitis - Year-over-year growth 2023-2028 (%); Exhibits66: Chart on Sub-acute sinusitis - Market size and forecast 2023-2028 ($ million); Exhibits67: Data Table on Sub-acute sinusitis - Market size and forecast 2023-2028 ($ million); Exhibits68: Chart on Sub-acute sinusitis - Year-over-year growth 2023-2028 (%); Exhibits69: Data Table on Sub-acute sinusitis - Year-over-year growth 2023-2028 (%); Exhibits70: Market opportunity by Disease Type ($ million); Exhibits71: Data Table on Market opportunity by Disease Type ($ million); Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits73: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits74: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits75: Chart on Geographic comparison; Exhibits76: Data Table on Geographic comparison; Exhibits77: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits94: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits95: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits98: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits99: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits101: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits102: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits103: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits104: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits105: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits106: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits107: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits108: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits109: Chart on France - Market size and forecast 2023-2028 ($ million); Exhibits110: Data Table on France - Market size and forecast 2023-2028 ($ million); Exhibits111: Chart on France - Year-over-year growth 2023-2028 (%); Exhibits112: Data Table on France - Year-over-year growth 2023-2028 (%); Exhibits113: Market opportunity By Geographical Landscape ($ million); Exhibits114: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits115: Impact of drivers and challenges in 2023 and 2028; Exhibits116: Overview on criticality of inputs and factors of differentiation; Exhibits117: Overview on factors of disruption; Exhibits118: Impact of key risks on business; Exhibits119: Companies covered; Exhibits120: Matrix on companies position and classification; Exhibits121: AbbVie Inc. - Overview; Exhibits122: AbbVie Inc. - Product / Service; Exhibits123: AbbVie Inc. - Key news; Exhibits124: AbbVie Inc. - Key offerings; Exhibits125: Alembic Pharmaceuticals Ltd. - Overview; Exhibits126: Alembic Pharmaceuticals Ltd. - Product / Service; Exhibits127: Alembic Pharmaceuticals Ltd. - Key offerings; Exhibits128: Bayer AG - Overview; Exhibits129: Bayer AG - Business segments; Exhibits130: Bayer AG - Key news; Exhibits131: Bayer AG - Key offerings; Exhibits132: Bayer AG - Segment focus; Exhibits133: Dr Reddys Laboratories Ltd. - Overview; Exhibits134: Dr Reddys Laboratories Ltd. - Business segments; Exhibits135: Dr Reddys Laboratories Ltd. - Key news; Exhibits136: Dr Reddys Laboratories Ltd. - Key offerings; Exhibits137: Dr Reddys Laboratories Ltd. - Segment focus; Exhibits138: Fresenius SE and Co. KGaA - Overview; Exhibits139: Fresenius SE and Co. KGaA - Business segments; Exhibits140: Fresenius SE and Co. KGaA - Key news; Exhibits141: Fresenius SE and Co. KGaA - Key offerings; Exhibits142: Fresenius SE and Co. KGaA - Segment focus; Exhibits143: GlaxoSmithKline Plc - Overview; Exhibits144: GlaxoSmithKline Plc - Business segments; Exhibits145: GlaxoSmithKline Plc - Key news; Exhibits146: GlaxoSmithKline Plc - Key offerings; Exhibits147: GlaxoSmithKline Plc - Segment focus; Exhibits148: Hikma Pharmaceuticals Plc - Overview; Exhibits149: Hikma Pharmaceuticals Plc - Business segments; Exhibits150: Hikma Pharmaceuticals Plc - Key news; Exhibits151: Hikma Pharmaceuticals Plc - Key offerings; Exhibits152: Hikma Pharmaceuticals Plc - Segment focus; Exhibits153: Johnson and Johnson Services Inc. - Overview; Exhibits154: Johnson and Johnson Services Inc. - Business segments; Exhibits155: Johnson and Johnson Services Inc. - Key news; Exhibits156: Johnson and Johnson Services Inc. - Key offerings; Exhibits157: Johnson and Johnson Services Inc. - Segment focus; Exhibits158: Merck and Co. Inc. - Overview; Exhibits159: Merck and Co. Inc. - Business segments; Exhibits160: Merck and Co. Inc. - Key news; Exhibits161: Merck and Co. Inc. - Key offerings; Exhibits162: Merck and Co. Inc. - Segment focus; Exhibits163: Neopharma Corp. - Overview; Exhibits164: Neopharma Corp. - Product / Service; Exhibits165: Neopharma Corp. - Key offerings; Exhibits166: Novartis AG - Overview; Exhibits167: Novartis AG - Business segments; Exhibits168: Novartis AG - Key news; Exhibits169: Novartis AG - Key offerings; Exhibits170: Novartis AG - Segment focus; Exhibits171: Pfizer Inc. - Overview; Exhibits172: Pfizer Inc. - Product / Service; Exhibits173: Pfizer Inc. - Key news; Exhibits174: Pfizer Inc. - Key offerings; Exhibits175: Sanofi SA - Overview; Exhibits176: Sanofi SA - Business segments; Exhibits177: Sanofi SA - Key news; Exhibits178: Sanofi SA - Key offerings; Exhibits179: Sanofi SA - Segment focus; Exhibits180: Sun Pharmaceutical Industries Ltd. - Overview; Exhibits181: Sun Pharmaceutical Industries Ltd. - Product / Service; Exhibits182: Sun Pharmaceutical Industries Ltd. - Key news; Exhibits183: Sun Pharmaceutical Industries Ltd. - Key offerings; Exhibits184: Teva Pharmaceutical Industries Ltd. - Overview; Exhibits185: Teva Pharmaceutical Industries Ltd. - Business segments; Exhibits186: Teva Pharmaceutical Industries Ltd. - Key news; Exhibits187: Teva Pharmaceutical Industries Ltd. - Key offerings; Exhibits188: Teva Pharmaceutical Industries Ltd. - Segment focus; Exhibits189: Inclusions checklist; Exhibits190: Exclusions checklist; Exhibits191: Currency conversion rates for US$; Exhibits192: Research methodology; Exhibits193: Information sources; Exhibits194: Data validation; Exhibits195: Validation techniques employed for market sizing; Exhibits196: Data synthesis; Exhibits197: 360 degree market analysis; Exhibits198: List of abbreviations